These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7366683)

  • 21. [Drug information. Diazoxide (Hyperstat, Essex Pharma)].
    Rasmussen K
    Ugeskr Laeger; 1976 Mar; 138(10):622-3. PubMed ID: 1251475
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of diazoxide on severe pulmonary hypertension].
    Raimondi GA
    Medicina (B Aires); 1990; 50(3):198-204. PubMed ID: 2130205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diazoxide: tolerance and complications].
    Grünfeld JP
    Therapie; 1980; 35(5):649-50. PubMed ID: 7209864
    [No Abstract]   [Full Text] [Related]  

  • 24. Diazoxide (hyperstat).
    Med Lett Drugs Ther; 1973 Jun; 15(13):53-6. PubMed ID: 4736480
    [No Abstract]   [Full Text] [Related]  

  • 25. [Infusion of diazoxide in severe arterial hypertension].
    Caramelo Díaz C; González Medel J; Díaz Curiel M; Fernández Guerrero M; Casado S
    Rev Clin Esp; 1982 Dec; 167(5):305-8. PubMed ID: 7167659
    [No Abstract]   [Full Text] [Related]  

  • 26. Pulmonary Hypertension Following Increased Dosing of Diazoxide in an Infant.
    Ohnishi Y; Okada S; Yasudo H; Kimura S; Suzuki Y; Hasegawa S
    Int Heart J; 2020 Sep; 61(5):1084-1087. PubMed ID: 32921661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.
    Chan NS; McLay J; Kenmure AC
    Br Heart J; 1987 Feb; 57(2):207-9. PubMed ID: 3814459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diazoxide in treatment of primary pulmonary hypertension.
    Wang SW; Pohl JE; Rowlands DJ; Wade EG
    Br Heart J; 1978 May; 40(5):572-4. PubMed ID: 656227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversibility of primary pulmonary hypertension during six years of treatment with oral diazoxide.
    Hall DR; Petch MC
    Br Heart J; 1987 Oct; 58(4):420. PubMed ID: 3676032
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diazoxide--a vasodilator in the treatment of hypertension].
    Moller BB; Kolendorf K
    Ugeskr Laeger; 1975 Oct; 137(42):2446-51. PubMed ID: 1179526
    [No Abstract]   [Full Text] [Related]  

  • 31. [Acute effect of diazoxide in patients with malignant arterial hypertension and renal insufficicney].
    Menéndez A; Patiño R
    Rev Esp Cardiol; 1972; 25(2):147-54. PubMed ID: 5050827
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral diazoxide contraindicated in severe hypertension with renal failure.
    Mussche MM; De Broe ME; Belpaire FM; Vermeulen A; Ringoir SM
    Clin Nephrol; 1975; 4(3):99-103. PubMed ID: 810287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapy of primary pulmonary hypertension].
    Both A
    Z Kreislaufforsch; 1970 Oct; 59(10):909-11. PubMed ID: 4992357
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hypertrichosis following prolonged use of i.v. diazoxide. Apropos of a case].
    Pérez Mijares R; Elosegui A; Praga M; Vidaur F; Izaguirre A; Argoitia A; López de Novales E
    Rev Clin Esp; 1981 Sep; 162(5):225-7. PubMed ID: 7313219
    [No Abstract]   [Full Text] [Related]  

  • 35. [Early pulmonary hypertension: current therapeutic prospectives].
    Pannarale G; Gaspardone A; Acconcia MC; Valente A
    Cardiologia; 1982 Sep; 27(9):883-94. PubMed ID: 6765450
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral diazoxide for hypoglycemia.
    Med Lett Drugs Ther; 1978 Dec; 20(25):110-1. PubMed ID: 732751
    [No Abstract]   [Full Text] [Related]  

  • 37. Partial reversal of hemolysis-associated pulmonary arterial hypertension in response to oral administration of L-arginine in a patient with hereditary spherocytosis.
    Smedema JP; Abrahams S; Louw VJ
    Acta Haematol; 2007; 118(3):167-8. PubMed ID: 17890851
    [No Abstract]   [Full Text] [Related]  

  • 38. Dangers of diazoxide.
    Michael CA
    Br Med J; 1972 Dec; 4(5841):669. PubMed ID: 4645909
    [No Abstract]   [Full Text] [Related]  

  • 39. [Vasodilator therapy in pulmonary arterial hypertension of unknown cause (primary)].
    Lupi Herrera E
    Arch Inst Cardiol Mex; 1982; 52(3):189-90. PubMed ID: 7114962
    [No Abstract]   [Full Text] [Related]  

  • 40. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
    Morris CR; Morris SM; Hagar W; Van Warmerdam J; Claster S; Kepka-Lenhart D; Machado L; Kuypers FA; Vichinsky EP
    Am J Respir Crit Care Med; 2003 Jul; 168(1):63-9. PubMed ID: 12626350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.